Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Gene Ther ; 13(14): 1080-7, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16554839

ABSTRACT

The ability of viruses to selectively target, replicate within, and destroy tumour cells without deleterious effects in normal cells (oncolysis), makes the use of viruses as an attractive tool for cancer treatment. Pancreatic adenocarcinoma, being insensitive to traditional therapy and having a rather poor prognosis, represents a suitable target to evaluate viral oncolysis as a novel therapeutic approach. Herpes simplex virus (HSV) has been reported to produce an oncolytic effect in cells overexpressing Ras. As Ras signalling is frequently aberrant in pancreatic cancer, we compared four pancreatic cell lines (which differ in the presence of mutated or wild-type ras) for their ability to support growth of gamma34.5-replication attenuated HSV-1 (R3616). Our data show that permissiveness to viral replication is neither associated with enhanced Ras signalling nor with defective PKR activity. By contrast, we provide evidence that disregulation of the PI 3-kinase signalling pathway allows conditionally replication-defective R3616 virus to overcome the cellular antiviral activity.


Subject(s)
Adenocarcinoma/therapy , Genetic Therapy/methods , Herpesvirus 1, Human/genetics , Oncolytic Virotherapy/methods , Pancreatic Neoplasms/therapy , Phosphatidylinositol 3-Kinases/metabolism , Adenocarcinoma/enzymology , Adenocarcinoma/virology , Cell Line, Tumor , Chromones/therapeutic use , Flavonoids/therapeutic use , Gene Deletion , Genes, ras , Herpes Simplex/complications , Humans , Immunoblotting/methods , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Morpholines/therapeutic use , Pancreatic Neoplasms/enzymology , Pancreatic Neoplasms/virology , Phosphoinositide-3 Kinase Inhibitors , Signal Transduction , Viral Proteins/genetics , Virus Replication/genetics
2.
Dev Dyn ; 218(3): 414-25, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10878607

ABSTRACT

Previous studies have demonstrated that the primordial pulmonary veins originate as an outgrowth of the atrial cells and anastomosis with the pulmonary venous plexus. As a consequence of this embryologic origin the tunica media of these vessels is composed of cardiac cells that express atrial specific markers (Lyons et al. [1990] J Cell Biol 111:2427-2436; Jones et al. [1994] Dev Dyn 200:117-128). We used transgenic mice for the cardiac troponin I (cTNI) gene and smooth muscle (SM) myosin heavy chain as differentiation markers, to analyze how cardiac and SM cells contribute to the formation and structural remodeling of the pulmonary veins during development. We show here that the tunica media of the adult mouse pulmonary veins contains an outer layer of cardiac cells and an intermediate SM cell compartment lining down on the inner endothelium. This structural organization is well expressed in the intrapulmonary veins from the beginning of vasculogenesis, with cardiac cells accumulating over preexisting roots of endothelial and SM cells and extending to the third bifurcation of the pulmonary branches without reaching the more distal tips of the vessels. On the other hand, SM cells, which are widely distributed in the intrapulmonary veins from the embryonic stage E16, accumulate also in the extrapulmonary branches and reach the posterior wall of the left atrium, including the orifices of the pulmonary veins. This event takes place around birth when the pulmonary blood flow starts to function properly. A model for the development of the pulmonary veins is presented, based upon our analysis.


Subject(s)
Muscle, Smooth, Vascular/cytology , Myocardium/cytology , Pulmonary Veins/embryology , Actins/analysis , Actins/immunology , Animals , Embryonic and Fetal Development/physiology , Female , Gene Expression , Genes, Reporter , Heart/embryology , Immunologic Techniques , In Situ Hybridization , Lung/blood supply , Lung/embryology , Male , Mice , Mice, Transgenic , Microscopy, Confocal , Models, Biological , Muscle, Smooth, Vascular/embryology , Muscle, Smooth, Vascular/immunology , Muscle, Smooth, Vascular/metabolism , Myocardium/immunology , Myocardium/metabolism , Myosins/analysis , Myosins/immunology , Platelet Endothelial Cell Adhesion Molecule-1/immunology , Pulmonary Veins/cytology , Pulmonary Veins/growth & development , Pulmonary Veins/metabolism , Troponin I/analysis , Troponin I/genetics , Troponin I/immunology , Tunica Media/cytology , Tunica Media/embryology
3.
J Cereb Blood Flow Metab ; 19(9): 1004-9, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10478652

ABSTRACT

Cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha can play pathogenetic or protective roles in stroke. They are increased in the brain after experimental ischemia and in the CSF of patients with stroke. However, their presence in the periphery is still controversial. To determine the source and time-course of cytokines in blood of stroke patients, IL-6 and TNF-alpha release from blood cells and serum levels were determined in 40 patients on days 1 through 2, 4, 10, 30, and 90 after stroke. Twenty healthy age-matched volunteers were used as controls. IL-6 and TNF-alpha release from stimulated blood cells was increased in stroke patients, compared to controls. A peak response (+224%) was observed at day 4 for IL-6, while TNF-alpha release was largely and significantly increased (about three-fold compared to controls) from day 1 to 2 until day 90 after stroke. The increase in IL-6 release was significantly higher in ischemic, compared to hemorrhagic strokes, at days 1 and 4. Circulating IL-6 was increased at each time point. The ischemic processes in the CNS induces a long-lasting activation of IL-6 and TNF-alpha production in peripheral blood cells, which are a major source of serum cytokines after stroke.


Subject(s)
Cerebrovascular Disorders/blood , Interleukin-6/blood , Tumor Necrosis Factor-alpha/metabolism , Acute Disease , Adult , Aged , Blood Cells/immunology , Cerebrovascular Disorders/immunology , Female , Humans , Male , Middle Aged , Time Factors
4.
J Muscle Res Cell Motil ; 20(2): 133-46, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10412085

ABSTRACT

The E-11 and 1-B8 monoclonal antibodies raised to the smooth muscle (SM)-specific SM22 protein from pig stomach were used to study the in vivo and in vitro phenotypic characteristics of myofibroblasts (MF) and SM cells (SMC) from the bladder detrusor muscle and serosal thickening of male rabbit. The 22-kDa SM22 band found in the SM extract appeared to be composed of distinct isoforms when examined in non-equilibrium two-dimensional gel electrophoresis (2D-EF): alpha (the most basic), beta, gamma, and delta (the most acidic) in the ratio of 34(alpha):23(beta):36(gamma):8(delta). Western blots of 2D-electrophoresed bladder extracts treated with E-11 and 1-B8 showed that alpha, beta, and delta, but not gamma isoforms were labeled with E-11, whereas alpha, beta, and gamma isoforms were stained with 1-B8. This differential immunoreactivity was not influenced by phosphorylation. The tissue distribution of SM22 immunostaining was heterogeneous in the bladder SM and serosal thickening developed as a consequence of partial outflow obstruction of the urinary bladder. At the cellular level, the 1-B8 and E-11 antibodies stained the SMC in a "diffuse" (the whole cytoplasm) and "honeycomb" (the peripheral cytoplasm) manner, whereas MF immunostaining was quite homogeneous. The two antibodies also reacted with cultured primary bladder SMC and MF grown in low serum conditions showing a heterogeneous SM22 cell distribution but an identical subcellular localization, i.e., the actin-containing filamentous network, distinguishable in part from that found in vivo. The immunocytochemical, Western blotting and 2D-EF patterns of MF from thickened serosa indicated that the gamma isoform alone is expressed in this tissue. This SM22 variant appeared before the completion of the cellular transition from MF to fully differentiated SMC. This pattern is reminiscent of bladder ontogenesis where SM22 expression in the developing bladder wall precedes that of SM myosin. Taken together these data suggest that: (i) SM22 isoforms are differently assorted in MF vs. SMC; (ii) SM22 is a SMC-lineage marker inasmuch as its expression occurs in an experimental condition characterized by a time-related cell phenotypic transition from MF to SMC, and (iii) cell conversion ability of serosal cells in the adult might take place via the reactivation of a specific "foetal" gene programme.


Subject(s)
Microfilament Proteins , Muscle Proteins/analysis , Muscle, Smooth/chemistry , Urinary Bladder/chemistry , Animals , Antibodies, Monoclonal , Cells, Cultured , Electrophoresis, Polyacrylamide Gel , Fibroblasts/chemistry , Fluorescent Antibody Technique, Indirect , Male , Rabbits
5.
Arterioscler Thromb Vasc Biol ; 19(6): 1393-404, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10364069

ABSTRACT

During the "response-to-injury" process after a mechanical insult to the porcine coronary arteries, the adventitial cells acquire the structural characteristics of myofibroblasts before being incorporated into smooth muscle (SM) layer. We assessed whether the SM-specific SM22 protein can be used as a tracer of adventitial cell-myofibroblast differentiation in the mild balloon injury of rabbit carotid artery. To achieve this goal, we used 2 monoclonal anti-SM22 antibodies (E-11 and 1-B8) and a molecular probe for the SM22alpha mRNA isoform in immunocytochemical and in situ hybridization experiments. The differentiation profile and the migratory and proliferative ability of activated adventitial cells were evaluated by a panel of antibodies to some SM and nonmuscle antigens and pulse- and end-labeling with bromo-deoxyuridine, respectively. In adventitial cells, SM22 antigenicity and SM22alpha mRNA were detectable at days 2 and 4 and, to a lesser extent, at days 7 and 21 after injury, particularly near the adventitia-media interface and mostly colocalizing with bromo-deoxyuridine-positive cells. The pulse-labeling experiments showed that the large majority of these cells penetrated the outermost layer of the tunica media without migrating to the subendothelial region. The phenotypic features of activated migrating and nonmigrating adventitial cells resembled those of vimentin-actin myofibroblast subtype and fetal-type SM cells. These findings indicate that a direct exposure of adventitia to the lumen is not required for phenotypic changes and proliferation/migration of these cells. After comparison of the SM22 expression in arterial vessels during early stages of development, we hypothesize that in the injured carotid artery the mural incorporation of adventitial cells and the spatiotemporal activation of SM22 expression are reminiscent of the vascular morphogenetic process and suggest the existence of a stem cell-like reservoir in adventitia. The early adventitial upregulation of SM22 expression in the injured vessel might be related to a multistep transition process in which nonmuscle cells are converted to myofibroblasts and, possibly, to SM cells.


Subject(s)
Carotid Arteries/chemistry , Microfilament Proteins , Muscle Proteins/analysis , Muscle, Smooth, Vascular/chemistry , Animals , Bromodeoxyuridine/metabolism , Carotid Arteries/pathology , Cell Differentiation , Cell Division , Cell Movement , Immunohistochemistry , Immunophenotyping , Male , Muscle Proteins/genetics , RNA, Messenger/analysis , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL
...